IBDQvsVBND
iShares iBonds Dec 2025 Term Corporate ETF against VIDENT US BOND STRATEGY ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBDQ | VBND | |
|---|---|---|
| Expense ratio | 0.10% | — |
| Assets | $2.3B | $453M |
| Net flow, 1 month | — | — |
| Net flow, 1 year | −$478M | — |
| Return, YTD | — | -6.0% |
| Return, 1 year | +0.1% | -6.5% |
| Avg daily volume | — | 23K |
| Holdings | 675 | 0 |
| Listed | Mar 11, 2015 | Jan 17, 2024 |
| Options market | No | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS